Vol 5 Issue 6

November/December 2001

 

Biological Terrorism


Since October 3, 2001, the CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. Both clinicians and laboratorians should be vigilant for symptoms or laboratory findings that suggest or indicate Bacillus anthracis infection (or any other rare bacterial or viral diseases), particularly among mail handlers.

 

Biological terrorism is defined as the intentional or threatened use of viruses, bacteria, fungi or toxins from living organisms to produce death or disease in humans, animals, or plants. Clues that may signal a bioterrorism attack include:

¨        large number of ill persons with a similar syndrome;

¨        increased incidence of a stable endemic disease;

¨        single case of a disease due to an uncommon agent;

¨        atypical presentation for a population;

¨        unusual disease presentation;

¨        increase in unexplained diseases or death;

¨        disease with an unusual geographic distribution;

¨        disease with an unusual seasonal onset;

¨        atypical transmission by aerosols, food or water that indicates sabotage; and

¨        unusual bacterial strain or antibiotic susceptibility.

 

This Newsletter will summarize and emphasize the most important points regarding the current situation, with respect to the anthrax material being sent through the mail.

 

1.      B. anthracis, the etiologic agent of anthrax, is a large, gram-positive, non-motile, spore-forming bacterial rod. The three virulence factors of B. anthracis are edema toxin, lethal toxin and a capsular antigen. Human anthrax has three major clinical forms: cutaneous, inhalation (pulmonary), and gastrointestinal.

 

2.      Cutaneous anthrax - the native type and most common form of anthrax seen in the US. The spore passes through the skin (cut or insect bite) and causes a painless (though may be "itchy"), swollen ulcer to develop. First a vesicle forms, then the roof of the lesion comes off, revealing a blackish base called an eschar. Once the ulcer has formed, the vegetative bacterium may then extend into the lymphatic and blood channels to bring about systemic illness and death in 10-20% of untreated individuals.

 

3.      Pulmonary anthrax - the most deadly form of anthrax. In this anthrax variant, the spores are inhaled and begin to grow in the lungs. From the lungs, the organisms are carried into adjacent lymph nodes and through the bloodstream to the entire body. After a few days to a week, flu-like symptoms develop, with increasing


difficulty breathing and, without early treatment, eventual shock and death in essentially 100% of cases.

 

4.      Gastro-intestinal anthrax – the least common form- If the organism is ingested in the meat of an infected animal, it attacks the gastrointestinal tract, causing nausea, vomiting (sometimes bloody), and severe diarrhea. If the patient is untreated, death occurs in 25% to over 50% of cases.

 

5.      Anthrax is treatable; however, if left untreated, anthrax in all forms can lead to septicemia and death.

 

6.      Anthrax is NOT spread from one person to another.

 

7.      Only the spores are small enough to be inhaled.

 

8.      If a patient presents with symptoms compatible with anthrax, providers should confirm the diagnosis by obtaining the appropriate laboratory specimens based on the clinical form of anthrax that is suspected.

¨        Cutaneous – vesicular fluid (swab without liquid transport media) and blood

¨        Inhalational – sputum / bronchial washings, blood, cerebrospinal fluid (if meningeal signs are present) 

¨        Gastrointestinal – blood, stool culture

¨        Note: specimens should be kept cold

  

9.      The RLA laboratories (Level A) adhere to CDC guidelines as follows:

¨        DO NOT screen asymptomatic individuals with/without known exposure.

¨        DO NOT accept powders or other environmental material for testing.

¨        DO NOT do environmental screening.

 

 

The Regional Laboratory Alliance laboratories will refer any suspicious organisms immediately to the appropriate state public health laboratory (Level B) for definitive testing. They will notify the KS Dept of Health 785-296-1343 or the MO Dept of Health 573-751-6001, dependent on the patient's address.

 

 

Additional Information to guide health-care providers may be found at http://www.bt.cdc.gov

 

 

References:

CDC website: http://www.bt.cdc.gov/DocumentsApp/faqanthrax.asp

Saint Luke's Regional Laboratories Clinical Laboratory Newsletter, October 2001

Children's Mercy Hospital & Clinics Memo, Dr. Marilyn Hamilton, October 25, 2001

Physicans Reference Laboratory website: http://www.prlnet.com/Anthrax.htm